Peptides should not replace diagnosis, rehabilitation, progressive loading, mobility work, strength training, or appropriate medical care
Human clinical trials are limited, and optimal dosing, long-term safety, and comparative effectiveness with other therapies remain unclear
Incorrect and impure products contain the wrong amino acid sequence or purity levels as low as 5% to 75%, filled with unknown chemical byproducts
If fatigue is ongoing, unexplained, or affecting your quality of life, it may be worth exploring whether B12 deficiency is a contributing factor
BPC-157 typically shows first results faster, within 7-14 days, especially for local injuries
However, FDA studies have proven that many patients benefit from a second booster treatment 4-8 weeks after the first to further enhance results